Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. 144 Insider Sale of Securities
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations · Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 4 Insider Changes in Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. EFFECT Other Notice of Effectiveness
  19. 8-K Event Regulation FD disclosure
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 8 of 32 · 632 filings